Ocular Therapeutix (OCUL) EBITDA (2013 - 2026)
Ocular Therapeutix (OCUL) reported EBITDA of -$80.26 million for Q2 2026, compared with -$66.62 million a year earlier.
Powered by 
Analysis
Ocular Therapeutix (OCUL) EBITDA (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ocular Therapeutix's EBITDA came in at -$308.46 million; for FY2025, it was -$265.69 million.
- By year, EBITDA came in at -$168 million in FY2024, -$79.4 million in FY2023, -$76.55 million in FY2022 and -$75.62 million in FY2021.
- Five-year quarterly EBITDA spans a low of -$92.06 million in Q1 2026 and a high of -$17.28 million in Q1 2022.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$92.06 million (Q1 2026), -$68.51 million (Q4 2025) and -$67.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Ocular Therapeutix | 1.45 Bn | -892.85 Mn | 11.46 Mn | -79.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -79.62 Mn |
| Mar 31, 2026 | -90.68 Mn |
| Dec 31, 2025 | -68.02 Mn |
| Sep 30, 2025 | -66.87 Mn |
| Jun 30, 2025 | -65.91 Mn |
| Mar 31, 2025 | -61.50 Mn |
| Dec 31, 2024 | -49.05 Mn |
| Sep 30, 2024 | -44.42 Mn |
| Jun 30, 2024 | -42.07 Mn |
| Mar 31, 2024 | -28.73 Mn |
| Dec 31, 2023 | -17.54 Mn |
| Sep 30, 2023 | -16.25 Mn |
| Jun 30, 2023 | -18.67 Mn |
| Mar 31, 2023 | -20.84 Mn |
| Dec 31, 2022 | -17.63 Mn |
| Sep 30, 2022 | -19.81 Mn |
| Jun 30, 2022 | -18.16 Mn |
| Mar 31, 2022 | -16.09 Mn |
| Dec 31, 2021 | -16.29 Mn |
| Sep 30, 2021 | -17.78 Mn |
API Access
Ocular Therapeutix EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();